secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001558370-24-002909
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma issues $2M 25% senior secured convertible note due 2025
-------------------------------------------------------------------------

- Principal $2,000,000, interest 25% p.a., matures March 7, 2025.
- Secured by all intellectual property, fixtures, and equipment.
- Convertible at $2.50 per share; 9.99% beneficial ownership limit applies.
- Default rate rises to 27%; events include non-payment or bankruptcy.
- Issued to accredited investor under Section 4(a)(2) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837024002909/0001558370-24-002909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837024002909/krbp-20240307x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-002909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer